3//SEC Filing
Oxford Sciences Innovation plc 3
Accession 0001104659-21-057937
CIK 0001828185other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 8:29 PM ET
Size
7.4 KB
Accession
0001104659-21-057937
Insider Transaction Report
Form 3
Vaccitech plcVACC]
Oxford Science Enterprises plc
10% Owner
Holdings
Series B redeemable convertible preferred shares
→ Ordinary Shares (1,661,184 underlying)Series A redeemable convertible preferred shares
→ Ordinary Shares (1,704,444 underlying)Ordinary Shares
→ Ordinary Shares (4,832,142 underlying)
Footnotes (3)
- [F1]Each ordinary share will be redesignated as 309 ordinary shares immediately prior to the closing of Vaccitech plc's (the "Issuer") initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The ordinary shares have no expiration date.
- [F2]Each Series A redeemable convertible preferred share will be redesignated as 309 ordinary shares immediately prior to the closing of the Issuer's initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The Series A redeemable convertible preferred shares have no expiration date.
- [F3]Each Series B preferred share will be redesignated as 309 ordinary shares immediately prior to the closing of the Issuer's initial public offering. The resulting number of ordinary shares of the Issuer are shown in column 3. The Series B preferred shares have no expiration date.
Documents
Issuer
Vaccitech plc
CIK 0001828185
Entity typeother
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001856079
Filing Metadata
- Form type
- 3
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 8:29 PM ET
- Size
- 7.4 KB